NCT01394029已完成不适用
International Sentinel Site Surveillance of Patients With Transfusional Hemosiderosis Treated With Deferasirox in Actual Practice Setting
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Adverse Drug Reactions
研究概览
简要总结
This study will observe patients with transfusional hemosiderosis treated with deferasirox in actual practice setting.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 2 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients treated with deferasirox for transfusional hemosiderosis according to the local prescribing information.
- •(the patients are either beginning treatment with deferasirox at the time of enrollment in the sentinel site monitoring or are currently under treatment with deferasirox and have started the treatment under prescription up to twelve months prior to enrollment in the sentinal site monitoring.
排除标准
- •Patients with non-transfusional hemosiderosis
- •Patients treated with deferasirox in an interventional clinical trial
- •Other protocol-defined inclusion/exclusion criteria may apply.
研究组 & 干预措施
deferasirox
干预措施: deferasirox (Drug)
结局指标
主要结局
Adverse Drug Reactions
时间窗: 3 years
Observed over 3 years for each patient
Serum Creatinine and liver enzyme levels
时间窗: 3 years
Observed over 3 years for each patient
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
4 期
Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron OverloadMyelodysplastic SyndromesBeta-ThalassemiaNCT00564941Novartis Pharmaceuticals309
已完成
3 期
Safety, Tolerability, and Efficacy of Deferasirox in MDSMyelodysplastic SyndromesHemosiderosisNCT00469560Gruppo Italiano Malattie EMatologiche dell'Adulto158
终止
2 期
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell TransplantIron OverloadMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesBreast CancerOvarian CancerLymphomaLeukemiaNeuroblastomaNCT00602446Masonic Cancer Center, University of Minnesota4
已完成
不适用
Retrospective Evaluation of Adult and Pediatric Transfusion-dependent Patients Treated With Deferasirox TherapyIron OverloadNCT01874405University of Campania "Luigi Vanvitelli"80
已完成
不适用
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With DeferasiroxAnemiaNCT00466063Novartis Pharmaceuticals108